Craniofacial abnormalities, which are primarily the result of abnormal craniofacial skeletal formation, are one of the most abundant human disorders. For instance, cleft palate occurs at a rate of 1 out of 1,000 newborns. To identify the primary cause of craniofacial abnormalities and establish a foundation for future therapeutic applications, it is critical to identify the signaling pathways that are involved in regulation of craniofacial skeletal development, and to determine their functional roles. We recently discovered a novel family of cysteine-rich, secretory proteins, R-spondin, which consists of four members in both humans and mice. We and others found that the R-spondin proteins are specific ligands for the Frizzled8 and LRP6 receptors and activate canonical Wnt signaling, leading to induction of beta-catenin-dependent gene expression. Gene expression analysis and a preliminary phenotype characterization of R-spondin2 null mutant mice strongly suggest that R-spondin2 is a novel genetic factor for cleft palate, and that it plays a key role in the development of the first branchial arch and its derived skeletal structures. The goal of proposed research is to elucidate the regulatory roles and signaling mechanisms of the R-spondin2 in craniofacial development. We propose: (i) to determine the in vivo role of the R-spondin2 gene in craniofacial development by analyzing molecular and cellular defects in R-spondin2 gene-targeted mutant mice, (ii) to determine whether R-spondin2 signaling in craniofacial development is mediated via the canonical Wnt signaling pathway, and (iii) to determine the regulatory roles of R-spondin in the noncanonical Wnt signaling pathway in cell culture model. We anticipate that our research will advance our understanding of the role of R-spondin2 and Wnt signaling in craniofacial development.
Many human craniofacial abnormalities are caused by perturbation of the specific signaling pathways that regulate craniofacial skeletal development. Information produced from this study will provide the foundation for future design and development of R-spondin-based therapeutic tools applicable to prevention and cure of human craniofacial skeletal diseases.
|Han, Xiang Hua; Jin, Yong-Ri; Tan, Leonard et al. (2014) Regulation of the follistatin gene by RSPO-LGR4 signaling via activation of the WNT/*-catenin pathway in skeletal myogenesis. Mol Cell Biol 34:752-64|
|Hoekstra, Elisa J; von Oerthel, Lars; van der Heide, Lars P et al. (2013) Lmx1a encodes a rostral set of mesodiencephalic dopaminergic neurons marked by the Wnt/B-catenin signaling activator R-spondin 2. PLoS One 8:e74049|
|Bradley, Cara K; Norton, Christine R; Chen, Ying et al. (2013) The snail family gene snai3 is not essential for embryogenesis in mice. PLoS One 8:e65344|
|Yoon, Jeong Kyo; Lee, Jin-Seon (2012) Cellular signaling and biological functions of R-spondins. Cell Signal 24:369-77|
|Jin, Yong-Ri; Yoon, Jeong Kyo (2012) The R-spondin family of proteins: emerging regulators of WNT signaling. Int J Biochem Cell Biol 44:2278-87|
|Jin, Yong-Ri; Han, Xiang Hua; Taketo, Makoto M et al. (2012) Wnt9b-dependent FGF signaling is crucial for outgrowth of the nasal and maxillary processes during upper jaw and lip development. Development 139:1821-30|
|Jin, Yong-Ri; Turcotte, Taryn J; Crocker, Alison L et al. (2011) The canonical Wnt signaling activator, R-spondin2, regulates craniofacial patterning and morphogenesis within the branchial arch through ectodermal-mesenchymal interaction. Dev Biol 352:1-13|
|Han, Xiang Hua; Jin, Yong-Ri; Seto, Marianne et al. (2011) A WNT/beta-catenin signaling activator, R-spondin, plays positive regulatory roles during skeletal myogenesis. J Biol Chem 286:10649-59|
|Chalamalasetty, Ravindra B; Dunty Jr, William C; Biris, Kristin K et al. (2011) The Wnt3a/Î²-catenin target gene Mesogenin1 controls the segmentation clock by activating a Notch signalling program. Nat Commun 2:390|
|Song, Jing; Semanik, Pamela; Sharma, Leena et al. (2010) Assessing physical activity in persons with knee osteoarthritis using accelerometers: data from the osteoarthritis initiative. Arthritis Care Res (Hoboken) 62:1724-32|